CDKN1A and cancer: Forty-four publications were further removed, among which 25 publications were unrelated with p21 3′ UTR rs1059234 polymorphism and cancer risk, 9 were meta-analysis, 4 were not case-control studies, 2 were reviews, 2 were letter to editor, 1 used cancer patients as controls and last one was overlapped with others.